Patient-specific characterization of the invasiveness and proliferation of low-grade gliomas using serial MR imaging and a mathematical model of tumor growth.

Low-grade gliomas (LGGs) represent a significant proportion of hemispheric gliomas in adults. Although less aggressive than glioblastomas (GBMs), they have a broad range of biologic behavior, and often a limited prognosis. The aim of the present study was to explore LGG growth kinetics through a combination of routine MRI imaging and a novel adaptation of a mathematical tumor model. MRI imaging in 14 retrospectively identified grade II LGGs that showed some tumor enhancement was used to assess tumor radii at two separate time-points. This information was combined with a reaction-diffusion partial-differential equation model of tumor growth to calculate diffusion (D) and proliferation (ρ) coefficients for each tumor, representing measures of tumor invasiveness and cellular multiplication, respectively. The results were compared to previously published data on GBMs. The average value of D was 0.034 mm(2)/day and ρ was 0.0056/day. Grade II LGGs had a broad range of D and ρ. On average, the proliferation coefficient ρ was significantly lower than previously published values for GBM, by about an order of magnitude. The diffusion coefficient, modeling invasiveness, however, was only slightly lower but without statistical significance. It was possible to calculate detailed growth kinetic parameters for some LGGs, potentially providing a new way to assess tumor aggressiveness and possibly gauge prognosis. Even within a single-grade (WHO II), LGGs were found to have broad range of D and ρ, possibly correlating to their variable biologic behavior. Overall, the model parameters suggest that LGG is less aggressive than GBM based primarily on a lower index of tumor proliferation rather than on lesser invasiveness.

[1]  Kristin R. Swanson,et al.  Toward Patient-Specific, Biologically Optimized Radiation Therapy Plans for the Treatment of Glioblastoma , 2013, PloS one.

[2]  R. Guillevin,et al.  Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas. , 2013, Neuro-oncology.

[3]  Luc Taillandier,et al.  Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates. , 2012, Neurosurgery.

[4]  R Grant,et al.  Guidelines on management of low‐grade gliomas: report of an EFNS–EANO * Task Force , 2010, European journal of neurology.

[5]  K Hendrickson,et al.  Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach , 2010, Physics in medicine and biology.

[6]  T. Cloughesy,et al.  Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. , 2009, Cancer research.

[7]  Olga Ciccarelli,et al.  Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. , 2009, Radiology.

[8]  Gargi Chakraborty,et al.  Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomas. , 2009, Cancer research.

[9]  K. Swanson,et al.  A mathematical model for brain tumor response to radiation therapy , 2009, Journal of mathematical biology.

[10]  Luc Taillandier,et al.  Computational modeling of the WHO grade II glioma dynamics: principles and applications to management paradigm , 2008, Neurosurgical Review.

[11]  K. Swanson,et al.  A mathematical modelling tool for predicting survival of individual patients following resection of glioblastoma: a proof of principle , 2007, British Journal of Cancer.

[12]  Kristin R. Swanson,et al.  The Evolution of Mathematical Modeling of Glioma Proliferation and Invasion , 2007, Journal of neuropathology and experimental neurology.

[13]  A. Péna,et al.  Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. , 2006, AJNR. American journal of neuroradiology.

[14]  M. Piérart,et al.  Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial , 2005, The Lancet.

[15]  Roberto Lent,et al.  Isotropic Fractionator: A Simple, Rapid Method for the Quantification of Total Cell and Neuron Numbers in the Brain , 2005, The Journal of Neuroscience.

[16]  Laurent Capelle,et al.  Continuous growth of mean tumor diameter in a subset of grade II gliomas , 2003, Annals of neurology.

[17]  J. Henson,et al.  Age-dependent rate of anaplastic transformation in low-grade astrocytoma , 1999, Neurology.

[18]  J. Murray,et al.  A mathematical model of glioma growth: the effect of chemotherapy on spatio‐temporal growth , 1995, Cell proliferation.

[19]  S. Vandenberg Current Diagnostic Concepts of Astrocytic Tumors , 1992, Journal of neuropathology and experimental neurology.

[20]  Douglas C. Miller,et al.  Treatment and Survival of Low-Grade Astrocytoma in Adults--1977–1988 , 1992 .

[21]  V. Arena,et al.  Survival of Patients with Well-Differentiated Astrocytomas Diagnosed in The Era of Computed Tomography , 1991 .

[22]  P. Kleihues,et al.  Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. , 1988, Journal of neurosurgery.

[23]  S. Kramer,et al.  The extent of intracranial gliomata at autopsy and its relationship to techniques used in radiation therapy of brain tumors. , 1960, The American journal of roentgenology, radium therapy, and nuclear medicine.

[24]  R. Soffietti,et al.  Natural History and Spontaneous Prognostic Factors , 2013 .

[25]  N. Pouratian,et al.  11 – Extraaxial Brain Tumors , 2010 .